Le Lézard
Classified in: Health, Science and technology
Subject: PDT

ONTARIO BRAIN INSTITUTE LAUNCHES CENTRE FOR ANALYTICS


TORONTO, April 23, 2024 /CNW/ - The Ontario Brain Institute (OBI) has opened the doors to its new Centre for Analytics with the launch of two transformative, data-driven projects.

"Data connections made possible through the Centre for Analytics will empower neuroscientists and neurotechnology experts to develop new ways of diagnosing and caring for people with brain disorders," said Dr. Tom Mikkelsen, President and Scientific Director of OBI. "This means creating innovative tools for screening risk, even before you know you are at risk, as well as continuous monitoring and feedback to enable people to get and monitor the treatment that they need."

Announced in 2023 with a five million dollar investment from the Government of Ontario, the Centre for Analytics represents an important step in OBI's commitment to translate the innovations that take place in the labs to directly benefit the lives of those living with brain disorders.

Dr. Francis Jeanson, Head of the Centre for Analytics (CfA), suggests that a multi-dimensional approach in neuroanalytics ? training, innovation, and translation ? will accelerate research discoveries, support the development of new treatments and technologies, and improve care for neurological conditions, concussion and brain injuries, and mental health.

"In Canada, and particularly here in Ontario, researchers ? in partnership with patients ? have made significant efforts to collect, de-identify and share health data to amplify neuroscience work across the world," Dr. Jeanson noted. "However, we now find ourselves at a critical point where we need to build up our expertise in complex data analytics, as well as provide training for scientific labs and neurotechnology companies looking to grow and evolve."

To support this pressing need for leadership in analytics, the CfA is focusing on:

Two inaugural analytics initiatives are already leveraging CfA resources and expertise, including data on Brain-CODE, OBI's state-of-the-art neuroinformatics platform, and a new cloud platform that provides advanced computing capabilities and analytical tooling.

The first project, led by Dr. Nardin Samuel of Cove Neurosciences, maps and models multi-modal brain imaging data to better classify neurodevelopment disorders, such as autism and attention-deficit/hyperactivity disorder.

The second initiative, headed by Western University's Dr. Lyle Muller, is developing new, large-scale neural networks that emulate how neurons fire and communicate. Dr. Muller's team is creating these networks to understand how neural circuits generate epilepsy seizures and to help predict if precise timing of non-invasive stimulation can control seizure activity.

"The Ontario Brain Institute's strong line-up of research networks is making amazing progress that is going to make a real difference in the lives of people with Alzheimer's, cerebral palsy and other brain disorders," stated Jill Dunlop, Ontario's Minister of Colleges and Universities. "The new Centre for Analytics will harness the talented Ontario researchers and post-secondary graduates to develop a new generation of analytics and AI tools that will help patients and their families for generations to come."

For more information about OBI's Centre for Analytics, as well as analytics initiatives underway with Dr. Samuel and Dr. Muller, visit braininstitute.ca/cfa.

ABOUT:

The Ontario Brain Institute is a provincially funded, not-for-profit organization that accelerates discovery and innovation, benefiting both patients and the economy. Our collaborative 'team science' approach promotes brain research, commercialization and care by connecting researchers, clinicians, industry, patients, and their advocates to improve the lives of those living with brain disorders.

SOURCE Ontario Brain Institute


These press releases may also interest you

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...

at 17:00
Sentynl...



News published on and distributed by: